Actively Recruiting
Talking for Change: Secondary Prevention of Child Sexual Abuse Perpetration
Led by Centre for Addiction and Mental Health · Updated on 2025-06-12
220
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
Sponsors
C
Centre for Addiction and Mental Health
Lead Sponsor
J
Johns Hopkins Bloomberg School of Public Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this patient preference randomized controlled trial is to investigate the efficacy of Talking for Change (TFC), an intervention for the secondary prevention of child sexual abuse and exploitation (CSA) perpetration. Blinded clinical raters will evaluate the primary endpoint-reductions in dynamic risk factors for sexual offending against children-and clients will provide self-reports to evaluate a second primary outcome-reductions in sexual contact with children, accessing online child sexual exploitation material (CSEM), and desire for sexual contact with children. Researchers will compare the following groups: (1) those receiving 20 weeks of the experimental TFC group psychotherapy; (2) those receiving 20 weeks of a control group psychotherapy targeting mental health and stress more broadly; and (3) those receiving no treatment.
CONDITIONS
Official Title
Talking for Change: Secondary Prevention of Child Sexual Abuse Perpetration
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Must be 18 years of age or older at the start of the study
- Must be able to provide informed consent
- Must be willing to comply with all study procedures
- Must be referred to the TFC program due to concerns about risk of sexual offending against children
- For benchmarking interview: must self-report concerns about sexual offending risk
- For benchmarking survey: must consent by checking appropriate box on informed consent form
You will not qualify if you...
- Unable to participate meaningfully in group psychotherapy due to intellectual disability, neurodiversity, active psychosis, or substance use
- Self-identified risk better explained by other conditions such as obsessive-compulsive disorder
- Non-male sex
- For benchmarking interview arm: non-male sex
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre for Addiction and Mental Health
Toronto, Ontario, Canada, M6J 1H4
Actively Recruiting
Research Team
A
Artemis Igoumenou, M.D., Ph.D.
CONTACT
I
Ian McPhail, Ph.D., C. Psych.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here